Brief: Carl Zeiss Meditec FY Adjusted EBIT Margin At 12.5%

Carl Zeiss Meditec AG

11/12/2024 06:05

Dec 11 (Reuters) - CARL ZEISS MEDITEC AG  AFXG.DE :
    * CARL ZEISS MEDITEC CLOSES FISCAL YEAR 2023/24 WITH SLIGHT
DECLINE IN REVENUE- ADJUSTED EBIT FORECAST ACHIEVED
    * FY ADJUSTED EBIT FALLS TO €245.9M FROM €362.9M
    * FY ADJUSTED EBIT MARGIN AT 12.5%, DOWN FROM 17.4% YEAR AGO
    * DIVIDEND PROPOSED AT €0.60, DOWN FROM €1.10
    * IN 2024/25 FISCAL YEAR, EBITA AND EBITA MARGIN ARE
EXPECTED
STABLE TO SLIGHTLY HIGHER
    * IN FOLLOWING YEARS, A GRADUAL INCREASE IN EBITA MARGIN IS
TARGETED. IN LONG TERM, COMPANY EXPECTS TO ACHIEVE AN EBITA
MARGIN IN RANGE OF AROUND 16-20% (2023/24: 12.0%)

Source text:  ID:nEQ5dKplSa 
Further company coverage:  AFXG.DE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))